Loading...

PerCP/Cyanine5.5 anti-human CD3 Antibody

Pricing & Availability
Clone
UCHT1 (See other available formats)
Regulatory Status
RUO
Workshop
III 471
Other Names
T3, CD3ε
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
UCHT1_PerCPCyanine55_CD3_Antibody_110518
Human peripheral blood lymphocytes were stained with CD3 (clone UCHT1) PerCP/Cyanine5.5 (filled histogram), or mouse IgG1, κ PerCP/Cyanine5.5 isotype control (open histogram).
  • UCHT1_PerCPCyanine55_CD3_Antibody_110518
    Human peripheral blood lymphocytes were stained with CD3 (clone UCHT1) PerCP/Cyanine5.5 (filled histogram), or mouse IgG1, κ PerCP/Cyanine5.5 isotype control (open histogram).
See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
300429 25 tests 141€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
300430 100 tests 306€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD chain of the CD3/T-cell receptor (TCR) complex which is composed of two CD3ε, one CD3γ, one CD3δ, one CD3ζ (CD247), and a T-cell receptor (α/β or γ/δ) heterodimer. It is found on all mature T cells, NKT cells, and some thymocytes. CD3, also known as T3, is a member of the immunoglobulin superfamily that plays a role in antigen recognition, signal transduction, and T cell activation.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The CD3 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections4,6,7 and formalin-fixed paraffin-embedded sections11, immunoprecipitation1, activation of T cells2,3,5, Western blotting9, and spatial biology (IBEX)16,17. The LEAF™ purified antibody (Endotoxin < 0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 300413, 300414, and 300432). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 300437, 300438, 300465, 300466, 300473, 300474) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References
  1. Salmeron A, et al. 1991. J. Immunol. 147:3047. (IP)
  2. Graves J, et al. 1991. J. Immunol. 146:2102. (Activ)
  3. Lafont V, et al. 2000. J. Biol. Chem. 275:19282. (Activ)
  4. Ryschich E, et al. 2003. Tissue Antigens 62:48. (IHC)
  5. Thompson AG, et al. 2004. J. Immunol. 173:1671. (Activ)
  6. Sakkas LI, et al. 1998. Clin. Diagn. Lab. Immun. 5:430. (IHC)
  7. Mack CL, et al. 2004. Pediatr. Res. 56:79. (IHC)
  8. Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed
  9. Van Dongen JJM, et al. 1988. Blood 71:603. (WB)
  10. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  11. Pollard, K. et al. 1987. J. Histochem. Cytochem. 35:1329. (IHC)
  12. Luckashenak N, et al. 2013. J. Immunol. 190:27. PubMed
  13. Laurent AJ, et al. 2014. PLoS One. 9:103683. PubMed
  14. Li J, et al. 2015. Cancer Res. 75:508. PubMed
  15. Stoeckius M, et al. 2017. Nat. Methods. 14:865-868. (PG)
  16. Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed
  17. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Jilkova Z, et al. 2017. Mediators Inflamm. 10.1155/2017/3214917. PubMed
  2. Shoda H, et al. 2017. Arthritis Research & Therapy . 10.1186/s13075-017-1308-y. PubMed
  3. Nakachi S, et al. 2017. Arthritis Research & Therapy . 10.1186/s13075-017-1309-x. PubMed
  4. Sumitomo S, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.001. PubMed
  5. Xu L, et al. 2018. Mol Oncol. 12:269. PubMed
  6. Shehata L, et al. 2019. Nat Commun. 10:1126. PubMed
  7. Shen M, et al. 2018. Int J Oncol. 53:317. PubMed
  8. Herrera FG, et al. 2019. Int J Radiat Oncol Biol Phys. 103:320. PubMed
  9. Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed
  10. Körner C et al. 2017. Cell host & microbe. 22(1):111-119 . PubMed
  11. Dulberger CL et al. 2017. Immunity. 46(6):1018-1029 . PubMed
  12. Ye C, et al. 2017. J Virol. 91:e01389-23. PubMed
  13. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  14. Shehata L, et al. 2019. Cell Rep. 28:3300. PubMed
  15. Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
  16. Etxeberria I, et al. 2020. Cancer Cell. 36(6):613-629. PubMed
  17. Leylek R, et al. 2020. Cell Rep. 32:108180. PubMed
  18. Poonia B, Pauza C 2014. PLoS One. 9:88884. PubMed
  19. Ribot J, et al. 2014. J Immunol. 192:2237. PubMed
  20. Armour K, et al. 2014. PLoS One. 9:109463. PubMed
  21. Teirlinck A, et al. 2015. Infect Immun . 83: 3732-3739. PubMed
  22. Gross C, et al. 2016. Proc Natl Acad Sci U S A. 113: 2973 - 2982. PubMed
  23. Nagafuchi Y, et al. 2016. Sci Rep. 6:29338. PubMed
  24. Yeung Y, et al. 2016. Nat Commun. 7:13376. PubMed
  25. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  26. Pritchett J, et al. 2016. J Infect Dis. 214(12):1911-1915. PubMed
  27. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  28. Poznanski SM, et al. 2021. Cell Metabolism. 33(6):1205-1220.e5. PubMed
  29. Portillo AL, et al. 2021. iScience. 24(6):102619. PubMed
  30. Fels JM, et al. 2021. Cell. 184(13):3486-3501.e21. PubMed
  31. Xu S, et al. 2021. Immunity. . PubMed
  32. Zhang M, et al. 2020. J Cell Mol Med. . PubMed
  33. Porsche CE, et al. 2021. JCI Insight. 6:. PubMed
  34. van Heerden D, et al. 2021. Int J Mol Sci. 22:. PubMed
  35. Nakano M, et al. 2021. Front Immunol. 12:713225. PubMed
  36. Scherer SD, et al. 2021. Breast Cancer Res. 23:100. PubMed
  37. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  38. Vendrame E, et al. 2020. AIDS. 34:801. PubMed
  39. Turner AW, et al. 2020. ACS Infect Dis. 6:1719. PubMed
  40. Khuzwayo S, et al. 2021. Front Immunol. 12:631410. PubMed
  41. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  42. Rajakumar SA, et al. 2021. Cell Rep Med. 2:100470. PubMed
  43. Brunk F, et al. 2021. Eur J Immunol. 51:2651. PubMed
  44. Aydin AM, et al. 2021. Int Immunopharmacol. 94:107481. PubMed
  45. Sicklinger F, et al. 2021. J Clin Invest. 131:. PubMed
  46. Li T, et al. 2022. Int J Infect Dis. 122:874. PubMed
  47. Rappazzo CG, et al. 2022. Immunity. 55:1710. PubMed
  48. Mbiribindi B, et al. 2020. Sci Rep. 10:19973. PubMed
  49. Li H, et al. 2022. Front Immunol. 13:988004. PubMed
  50. Song R, et al. 2022. Front Immunol. 13:1028246. PubMed
  51. Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
  52. He T, et al. 2022. Liver Int. 42:1287. PubMed
  53. Höfle J, et al. 2022. EMBO Rep. 23:e54133. PubMed
  54. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  55. Sun W, et al. 2023. Nature. 614:309. PubMed
  56. Guo Q, et al. 2023. Front Public Health. 10:1067342. PubMed
  57. Peng W, et al. 2023. Cells. 12: . PubMed
  58. Larivière L, et al. 2023. Int J Pharm X. 5:100157. PubMed
  59. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  60. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  61. Zhang S, et al. 2023. J Clin Med. 12: . PubMed
  62. Freitag PC, et al. 2023. Mol Ther Methods Clin Dev. 29:120. PubMed
  63. Chernyshev M, et al. 2023. Nat Commun. 14:2249. PubMed
  64. Lu T, et al. 2023. J Med Virol. 95:e28730. PubMed
RRID
AB_893301 (BioLegend Cat. No. 300429)
AB_893299 (BioLegend Cat. No. 300430)

Antigen Details

Structure
Ig superfamily, with the subunits of CD3γ, CD3δ, CD3ζ (CD247) and TCR (α/β or γ/δ) forms CD3/TCR complex, 20 kD
Distribution

Mature T and NK T cells, thymocyte differentiation

Function
Antigen recognition, signal transduction, T cell activation
Ligand/Receptor
Peptide antigen bound to MHC
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology, Innate Immunity
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego.
2. Beverly P, et al. 1981. Eur. J. Immunol. 11:329.
3. Lanier L, et al. 1986. J. Immunol. 137:2501-2507.

Gene ID
916 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Go To Top Version: 2    Revision Date: 11/05/2018

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account